Zamboglou DC, Spohn DSKB, Ruf PJ, Benndorf DM, et al. PSMA-PET- and MRI-based focal dose escalated radiotherapy of primary prostate cancer: planned safety analysis of a non-randomized 2-armed phase II trial (ARO2020-01). Int J Radiat Oncol Biol Phys 2022 Apr 22. pii: S0360-3016(22)00333.
PMID: 35469897